Retinitis pigmentosa 3
MONDO:0010227Any retinitis pigmentosa in which the cause of the disease is a mutation in the RPGR gene.
Also known as: RP3, RPGR retinitis pigmentosa, retinitis pigmentosa 3, retinitis pigmentosa caused by mutation in RPGR, retinitis pigmentosa type 3, Choroidoretinal Degeneration with retinal reflex in heterozygous Women, cone-rod Degeneration, X-linked, retinitis pigmentosa 15
32 clinical trials for this condition and its sub-types, 7 tagged with Retinitis pigmentosa 3 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Gene Therapy's lasting effects on vision tracked in Long-Term study
Disease control CompletedThis study follows people with two inherited eye conditions—choroideremia and X-linked retinitis pigmentosa—who previously received gene therapy. Researchers monitor their safety and vision over several years to see if the treatment remains safe and helps preserve sight. Particip…
Phase 3 • Sponsor: NightstaRx Ltd, a Biogen Company • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Gene therapy offers hope for rare blindness
Disease control CompletedThis Phase 3 trial tests a gene therapy called botaretigene sparoparvovec for X-linked retinitis pigmentosa, a genetic condition that causes progressive vision loss. The study involves 105 participants who receive the therapy via injection under the retina. The main goal is to se…
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Gene therapy watch: 5-Year safety check for inherited blindness treatment
Disease control CompletedThis study followed 42 people who received a gene therapy for X-linked retinitis pigmentosa, an inherited eye disease that causes blindness. The goal was to check the treatment's safety over up to 5 years. Researchers also looked at whether patients' vision and ability to move ar…
Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC